Evogene Ltd (EVGN)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live...

Evogene Shares Decline After Revenue Miss Despite Stronger-Than-Expected Earnings (EVGN)

Evogene Ltd. (NASDAQ:EVGN) reported first-quarter results on Wednesday that exceeded earnings expectations but missed analyst revenue forecasts...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Evogene to Present at the 24th Schrödinger European User Group Meeting

Evogene to Present at the 24th Schrödinger European User Group Meeting PR Newswire REHOVOT, Israel, May 12...

Evogene Schedules First Quarter 2026 Financial Results Release

Evogene Schedules First Quarter 2026 Financial Results Release PR Newswire REHOVOT, Israel, May 7, 2026...

Form EFFECT - Notice of Effectiveness

Form 3 - Initial statement of beneficial ownership of securities

Form EFFECT - Notice of Effectiveness

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]